These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 5793435)

  • 1. A clinical trial of oral cholecystographic agents: telepaque, sodium oragrafin and calcium oragrafin.
    Tishler JM; Gold R
    J Can Assoc Radiol; 1969 Jun; 20(2):102-5. PubMed ID: 5793435
    [No Abstract]   [Full Text] [Related]  

  • 2. Uricosuric action of cholecystographic agents. A possible factor in nephrotoxicity.
    Mudge GH
    N Engl J Med; 1971 Apr; 284(17):929-33. PubMed ID: 5551801
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effects of three oral cholecystographic agents on laboratory data. Clinical chemical determinations and urinary tests (author's transl)].
    Kasezawa N; Tazawa R; Urushibata S; Kobayashi M
    Rinsho Byori; 1974 Jun; 22(6):440-4. PubMed ID: 4472714
    [No Abstract]   [Full Text] [Related]  

  • 4. [The uricosuric effect of bilopaque (sodium tyropanoate). A contribution to the problem of nephro-toxicity of oral biliary contrast media].
    Burgener FA; Fischer HW
    Fortschr Geb Rontgenstr Nuklearmed; 1972 Dec; 117(6):685-8. PubMed ID: 4346201
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparative trial of two oral cholecystographic contrast media--iocetamic acid (Cholebrin) and iopanoic acid (Telepaque).
    Fielding JA; Whitehouse GH
    Clin Radiol; 1979 Jan; 30(1):45-8. PubMed ID: 154372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oragrafin, a new cholecystographic medium: a double-blind comparison with Telepaque.
    JUHL JH; COOPERMAN LR; CRUMMY AB
    Radiology; 1963 Jan; 80():87-91. PubMed ID: 13957983
    [No Abstract]   [Full Text] [Related]  

  • 7. Results obtained in comparative radiographie, clinical and clinical-chemical studies in iocetamic acid (DRC 1201) and iopanoic acid.
    Hekster RE
    Radiol Clin Biol; 1968; 37(6):338-52. PubMed ID: 5714064
    [No Abstract]   [Full Text] [Related]  

  • 8. [The uricosuric action of contrast media used for the opacification of bile ducts (apropos of 27 cases)].
    Billis A; Dimopoulos C; Giamarellou H; Zoumbouli I; Papadimitriou A; Sagiorgis G; Kaniouras N; Scouteris M; Daïcos G
    Ann Med Interne (Paris); 1973 Dec; 124(12):853-62. PubMed ID: 4598722
    [No Abstract]   [Full Text] [Related]  

  • 9. [The effect of diarrhea on gallbladder opacification during oral cholecystography: comparison of two cholecystographic agents (author's transl)].
    Fukuda K; Nanjo M; Harada J; Sekiya T; Kanehira Y; Anno I; Takayama M; Watanabe H; Yamada T; Yamaguchi M; Tada S
    Rinsho Hoshasen; 1979 Mar; 24(3):379-84. PubMed ID: 547079
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparison of three cholecystographic agents. A double-blind study with and without a prior fatty meal.
    Stanley RJ; Melson GL; Cubillo E; Hesker AE
    Radiology; 1974 Sep; 112(3):513-7. PubMed ID: 4602063
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical comparison of tyropanoate sodium, ipodate sodium, and iopanoic acid.
    Russell JG; Frederick PR
    Radiology; 1974 Sep; 112(3):519-23. PubMed ID: 4843279
    [No Abstract]   [Full Text] [Related]  

  • 12. A CLINICAL TRIAL OF ORAL CHOLECYSTOGRAPHIC MEDIA: TELEPAQUE, BILOPTIN, OSBIL TABLETS AND OSBIL CAPSULES.
    HEALEY T; GRAINGER RG
    Br J Radiol; 1965 Jan; 38():57-62. PubMed ID: 14236022
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical comparison of two contrast agents for oral cholecystography: radiologic efficacy and drug safety of iopanoic acid and iopronic acid.
    Hedlund L; Putman CE; Burrell M
    Yale J Biol Med; 1979; 52(3):257-62. PubMed ID: 380184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative clinical evaluation of a new oral cholecystographic medium, orabilex with telepaque.
    O'LACO JP; WILCOX WA
    Wis Med J; 1960 Apr; 59():249-51. PubMed ID: 14428090
    [No Abstract]   [Full Text] [Related]  

  • 15. A double-blind study of oral cholecystographic media: orabilex and telepaque.
    MORGAN LA; PARKS RE
    Radiology; 1960 Mar; 74():436-41. PubMed ID: 14424118
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical trial of cholecystographic contrast media].
    Colagrande C; Priolo F; Parrella RE
    Radiol Med; 1970 Sep; 56(9):825-31. PubMed ID: 5210610
    [No Abstract]   [Full Text] [Related]  

  • 17. An oral cholecystographic method using telepaque with demonstration of the common and cystic ducts.
    GRUGAN RA
    Radiology; 1953 Oct; 61(4):633-6. PubMed ID: 13100674
    [No Abstract]   [Full Text] [Related]  

  • 18. ORAGRAFIN AS A SUPPLEMENTAL CONTRAST AGENT IN ORAL CHOLECYSTOGRAPHY.
    RICHARDSON GA; SCHREIBER MH
    Tex State J Med; 1963 Aug; 59():788-9. PubMed ID: 14044597
    [No Abstract]   [Full Text] [Related]  

  • 19. [New cholecystographic contrast medium; telepaque].
    BRODEUR P; DUFRESNE M
    Union Med Can; 1953 Jan; 82(1):64-5. PubMed ID: 13057015
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical review 129: Oral cholecystographic agents and the thyroid.
    Braga M; Cooper DS
    J Clin Endocrinol Metab; 2001 May; 86(5):1853-60. PubMed ID: 11344170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.